MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES: $111M Department of Health and Human Services Grant
Summary
The Michigan Department of Health and Human Services received a $111M grant from SAMHSA for opioid response, focusing on prevention, treatment, and recovery. As a state-level award, no publicly traded companies directly benefit, but the contract signals continued federal investment in opioid abatement, supporting healthcare service providers and pharmaceutical manufacturers indirectly.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No publicly traded entity is directly funded by this $111M state grant.
- 2.The opioid treatment sector continues to receive substantial federal support, benefiting generic drug makers and treatment service providers.
- 3.Investors should monitor SAMHSA's SOR grant announcements for sector-wide demand signals but avoid over-attribution to specific companies.
Market Implications
The contract is a routine renewal of state-level opioid funding and does not create a material event for any single public company. The broader trend of sustained federal opioid spending (over $1B annually) provides a steady tailwind for pharmaceutical firms specializing in addiction treatments and naloxone distribution. However, without a direct tie to a specific ticker, the market impact is negligible for equity traders.
Full Analysis
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the Michigan Department of Health and Human Services a $111M project grant under the State Opioid Response (SOR) initiative. The award runs from September 2024 to September 2027 and targets adults aged 25-44 with opioid use disorder, along with specific populations such as African Americans, adolescents, and American Indians/Alaska Natives. The program aims to expand access to naloxone, medication-assisted treatment (MOUD), harm reduction services, and recovery support. Since the recipient is a state government entity rather than a publicly traded company, no direct stock market impact is attributable. However, this contract is part of a broader federal push (over $1.5B annually in SOR grants) that benefits the entire opioid treatment ecosystem, including pharmaceutical firms producing buprenorphine, naloxone, and naltrexone, as well as behavioral health service providers. The related bills in the HillSignal database (e.g., S5006, S5116) are tangentially healthcare-related but lack specific provisions for opioid funding. Historically, similar SOR grants have sustained demand for addiction treatment services and medications, though the impact on individual public companies remains diffuse. Supply chain beneficiaries include manufacturers of naloxone (e.g., Amphastar, Emergent BioSolutions) and buprenorphine (Indivior, Dr. Reddy's), but no specific contract-level revenue attribution is possible. The contract's multi-year nature provides stable funding for Michigan's opioid response infrastructure.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES
Award Amount
$110,940,860
Awarding Agency
Department of Health and Human Services
Sub-Agency
Substance Abuse and Mental Health Services Administration
Contract Type
PROJECT GRANT (B)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →